TGTX Tg Therapeutics PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: TGTX
- PE Ratio
As of Jun 20, 2025, the Tg Therapeutics stock's price-to-earnings ratio is 133.41. This results from the current EPS of $0.27 and stock price of $36.02.
TGTX PE ratio history
The PE ratio of Tg Therapeutics has averaged 120.51 over the last two years. The current P/E ratio of 133.41 is 11% higher than the historical average. In the past two years, TGTX's PE ratio peaked in the Dec 2023 quarter at 189.78, when the stock price was $17.08 and the EPS was $0.09. The lowest point was in the Jun 2024 quarter, when it reached 26.16 with a price of $17.79 and an EPS of $0.68.
Tg Therapeutics PE ratio by year
Maximum annual decrease: -0.87% in 2024
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 188.13 | -0.87% | $30.1 | $0.16 |
| 2023 | 189.78 | N/A | $17.08 | $0.09 |
| 2022 | N/A | N/A | $11.83 | -$1.65 |
| 2021 | N/A | N/A | $19 | -$2.63 |
| 2020 | N/A | N/A | $52.02 | -$2.42 |
| 2019 | N/A | N/A | $11.1 | -$1.96 |
| 2018 | N/A | N/A | $4.1 | -$2.3 |
| 2017 | N/A | N/A | $8.2 | -$1.91 |
| 2016 | N/A | N/A | $4.65 | -$1.6 |
| 2015 | N/A | N/A | $11.93 | -$1.38 |
| 2014 | N/A | N/A | $15.84 | -$1.64 |
| 2013 | N/A | N/A | $3.9 | -$0.81 |
| 2012 | N/A | N/A | $3.64 | -$1.38 |
| 2011 | N/A | N/A | $1.13 | -$0.44 |
| 2010 | 6.66 | N/A | $112.5 | $16.88 |
Tg Therapeutics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 146.04 | -22.37% | $39.43 | $0.27 |
| Dec 2024 | 188.13 | N/A | $30.1 | $0.16 |
| Sep 2024 | N/A | N/A | $23.39 | -$0.09 |
| Jun 2024 | 26.16 | -50.12% | $17.79 | $0.68 |
| Mar 2024 | 52.45 | -72.36% | $15.21 | $0.29 |
| Dec 2023 | 189.78 | N/A | $17.08 | $0.09 |
| Sep 2023 | N/A | N/A | $8.36 | -$0.39 |
| Jun 2023 | N/A | N/A | $24.84 | -$1.45 |
| Mar 2023 | N/A | N/A | $15.04 | -$1.41 |
| Dec 2022 | N/A | N/A | $11.83 | -$1.65 |
| Sep 2022 | N/A | N/A | $5.92 | -$1.77 |
| Jun 2022 | N/A | N/A | $4.25 | -$2.16 |
| Mar 2022 | N/A | N/A | $9.51 | -$2.45 |
| Dec 2021 | N/A | N/A | $19 | -$2.63 |
| Sep 2021 | N/A | N/A | $33.28 | -$2.65 |
TGTX Price vs fair value
TGTX average PE ratio chart
The current PE ratio of TGTX is higher than its 3, 5 and 10-year historical averages.
TGTX PE vs peers
TGTX's PE ratio stands higher than its peer stocks ALKS and NERV.
| Stock name | PE ratio | Market cap |
|---|---|---|
| NERV Minerva Neurosciences Inc | 2.16 | $12.38M |
| ALKS Alkermes plc | 13.53 | $4.8B |
| TGTX Tg Therapeutics Inc | 133.41 | $5.72B |
Frequently asked questions
What is Tg Therapeutics's PE ratio?
The price to earnings ratio for TGTX stock as of Jun 20, 2025, stands at 133.41.
What is the 3-year average PE ratio for Tg Therapeutics (TGTX)?
The 3-year average price to earnings ratio for TGTX stock is 120.51.
What is the 5-year average PE ratio for Tg Therapeutics (TGTX)?
The 5-year average price to earnings ratio for TGTX stock is 120.51.
What is the highest PE ratio for TGTX?
The highest quarterly PE ratio in the last two years has been 189.78 and it was in the Dec 2023 quarter.
How does the current PE ratio for TGTX compare to its historical average?
TGTX's price to earnings ratio is currently 11% above its 2-year historical average.
Why is Tg Therapeutics's PE ratio so high?
TGTX's stock price is trading at a higher multiple of earnings, which is why its PE ratio of 133.41 is considered high.
How is TGTX's PE ratio calculated (Tg Therapeutics PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 20, 2025), Tg Therapeutics's stock price is $36.02. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.27. Therefore, Tg Therapeutics's PE ratio for today is 133.41. PE RATIO(133.41) = STOCK PRICE($36.02) / TTM EPS($0.27)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.